/5
0 avis
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Archive ouverte
Edité par CCSD ; Lippincott, Williams & Wilkins -
International audience
Consulter en ligne
Chargement des enrichissements...